|
Originally published In Press as doi:10.1074/jbc.M703090200 on November 26, 2007
J. Biol. Chem., Vol. 283, Issue 4, 2139-2146, January 25, 2008
Prostaglandin E2 Regulates Angiogenesis via Activation of Fibroblast Growth Factor Receptor-1*
Federica Finetti,
Raffaella Solito,
Lucia Morbidelli,
Antonio Giachetti,
Marina Ziche, and
Sandra Donnini, Supported by funds from NuGO (FOOD-CT-2004-5063601
From the
Department of Molecular Biology, University of Siena, Via Aldo Moro, 2, 53100 Siena, Italy
Prostaglandin E2 (PGE2) behaves as a mitogen in epithelial tumor cells as well as in many other cell types. We investigated the actions of PGE2 on microvascular endothelial cells (capillary venular endothelial cells) with the purpose of delineating the signaling pathway leading to the acquisition of the angiogenic phenotype and to new vessel formation. PGE2 (100 nM) produced activation of the fibroblast growth factor receptor 1 (FGFR-1), as measured by its phosphorylation, but not of vascular endothelial growth factor receptor 2. PGE2 stimulated the EP3 subtype receptor, as deduced by abrogation of EP3 G i subunit activity through pertussis toxin. Consistent with this result, in human umbilical venular endothelial cells missing the EP3 receptor, PGE2 did not phosphorylate FGFR-1. Upon binding to its receptor, PGE2 initiated an autocrine/paracrine signaling cascade involving the intracellular activation of c-Src, activation of matrix metalloproteinase (predominantly MMP2), which in turn caused the mobilization of membrane-anchored fibroblast growth factor-2 (FGF-2). In fact, in cells unable to release FGF-2 the transfection with both FGFR-1 and EP3 did not result in FGFR-1 phosphorylation in response to PGE2. Relevance for the FGF2-FGFR-1 system was highlighted by confocal analysis, showing receptor internalization after cell exposure to the prostanoid. ERK1/2 appeared to be the distal signal involved, its phosphorylation being sensitive to either cSrc inhibitor or FGFR-1 blocker. Finally, PGE2 stimulated cell migration and capillary formation in aortic rings, which were severely reduced by inhibitors of signaling molecules or by receptor antagonist. In conclusion, this study provides evidence for the involvement of FGFR-1 through FGF2 in eliciting PGE2 angiogenic responses. This signaling pattern is similar to the autocrine-paracrine mechanism which operates in endothelial cells to support neovascular growth.
Received for publication, April 12, 2007
, and in revised form, November 26, 2007.
* This work was supported in part by European Union project EICOSANOX FP6 funding (LSHM-CT-2004-0050333). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1S and 2S.
1 To whom correspondence should be addressed: Dept. of Molecular Biology, Pharmacology Angiogenesis Laboratory, University of Siena, Via Aldo Moro, 2, 53100, Siena, Italy. Tel.: 39-0577-234439; Fax: 39-0577-234343; E-mail: donnini4{at}unisi.it.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Carli, C. N. Metz, Y. Al-Abed, P. H. Naccache, and A. Akoum
Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways
Endocrinology,
July 1, 2009;
150(7):
3128 - 3137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Bauer and E. A. Rondini
REVIEW PAPER: The Role of Inflammation in Mouse Pulmonary Neoplasia
Vet. Pathol.,
May 1, 2009;
46(3):
369 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Brant and J. P. Fabisiak
Nickel and the Microbial Toxin, MALP-2, Stimulate Proangiogenic Mediators from Human Lung Fibroblasts via a HIF-1{alpha} and COX-2-Mediated Pathway
Toxicol. Sci.,
January 1, 2009;
107(1):
227 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakanishi, D. C. Montrose, P. Clark, P. R. Nambiar, G. S. Belinsky, K. P. Claffey, D. Xu, and D. W. Rosenberg
Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
Cancer Res.,
May 1, 2008;
68(9):
3251 - 3259.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|